Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1236 participants
INTERVENTIONAL
2024-09-05
2024-10-21
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Impact of Cigarette and E-cigarette Menthol Regulation on Current Smokers of Menthol Cigarettes
NCT05896033
Trial on the Effectiveness of Mindfulness Training for Smokers
NCT01093599
Effectiveness of a Web-Assisted Quitline for Smokeless Tobacco Users
NCT00820495
Impact of Graphic Cigarette Warnings
NCT02247908
Improving the Population-Wide Effectiveness of U.S. Tobacco Cessation Quitlines
NCT01087905
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Recruitment: A survey company will recruit \~1,400 participants. Participants will complete a screener to confirm that they are US adults (ages 21+), currently smoke menthol cigarettes, and are able to read and speak English. A portion of the sample will be nationally representative, and a portion will be a convenience sample.
Informed Consent: The consent form will appear on the first page of the survey. Participants will provide their consent to be in the trial by clicking on a button that forwards to the next page of the survey.
Randomization: After consent, the survey software will randomize participants to 1 of 5 themes between-subjects. The design will include 3 intervention ad themes about quitting smoking (self-efficacy ads, response efficacy ads, or motivation ads) and 2 control ad themes about neutral non-smoking related topics (reading or password safety).
Each participant will view 6 ads on their assigned theme, presented in a random order.
Assessment: Participants will complete a \~15 minute online survey one time.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ads about response efficacy for quitting smoking
Participants will view ads designed to increase response efficacy for quitting cigarettes.
Intervention ads
The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Ads about self-efficacy for quitting smoking
Participants will view ads designed to increase self-efficacy to quit smoking.
Intervention ads
The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Ads about motivation to quit smoking
Participants will view ads designed to increase motivation to quit smoking.
Intervention ads
The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Ads about reading
Participants will view non-smoking related ads on the benefits of reading.
Control ads
The ads will be on topics unrelated to quitting smoking, formatted as black text on a white field. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Ads about passwords
Participants will view non-smoking related ads on passwords.
Control ads
The ads will be on topics unrelated to quitting smoking, formatted as black text on a white field. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intervention ads
The ads will be on topics to encourage quitting smoking, formatted as multi-color text with graphic elements. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Control ads
The ads will be on topics unrelated to quitting smoking, formatted as black text on a white field. Trial investigators developed the ads and optimized them to be readable when delivered in an SMS text message.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Be a member of the AmeriSpeak online survey panel or their convenience sample
* Live in the US
* Be age 21 years or older
* Read and speak English
Exclusion Criteria
* Not be a member of the AmeriSpeak online survey panel or their convenience sample
* Not live in the US
* Be younger than age 21 years
* Not be able to read and speak English
21 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Food and Drug Administration (FDA)
FED
National Institute on Drug Abuse (NIDA)
NIH
UNC Lineberger Comprehensive Cancer Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Noel Brewer, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Marissa G Hall, PhD
Role: PRINCIPAL_INVESTIGATOR
University of North Carolina, Chapel Hill
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of North Carolina
Chapel Hill, North Carolina, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
UNC Lineberger Comprehensive Cancer Center Clinical Trials
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
23-2450
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.